Daihan

Daihan Pharm is a leading South Korean pharmaceutical company specializing in the manufacture of intravenous (IV) solutions and essential hospital medicines. Founded in 1945, the company maintains a significant market share in the domestic IV fluid market, producing basic solutions like saline and dextrose as well as advanced total parenteral nutrition (TPN) products. In addition to its core fluid business, Daihan Pharm develops and markets a range of therapeutic products including antibiotics, respiratory treatments, and circulatory system drugs. The company operates high-capacity, automated manufacturing facilities and is a critical supplier to the South Korean healthcare system. It is recognized for its stable financial performance and its role in providing foundational medical supplies.